Protocol Ledger

NCT06957418 · Phase II · RECRUITING

Alzheimer's Tau Platform: Master Protocol

Interventional Phase II clinical trial protocol NCT06957418 sponsored by Paul S. Aisen in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-07-06 Enrollment: 900 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06957418
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)900 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06957418
Protocol FieldVerified Registry Value
NCT IdentifierNCT06957418
Consolidated Lead SponsorPaul S. Aisen
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment900 participants (ESTIMATED)
Registered Start Date2026-07-06
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06957418
Hospital Research SiteLocationSite Profile
UCSF Medical Center and Helen Diller Cancer CenterSan Francisco, CAOpen Hospital Dossier ->
Brigham and Women's HospitalBoston, MAOpen Hospital Dossier ->
Vanderbilt University Medical CenterNashville, TNOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI